Mass layoffs at the FDA, including senior negotiators, have disrupted the process of reauthorizing user fee programs that fund the agency's...

Kerala's Drugs Control Department is set to launch the 'nPROUD' project, a first in the country, to collect and dispose of expired and unus...

The document is in the final stages of completion. It will include procedures to be followed for disposal, collection, storage and transpor...

To keep a gauge if a doctor is prescribing drugs manufactured by particular pharmaceutical companies, medical representatives collect weekl...

Madras HC in a recent case ruled that input tax credit availed by a company or a manufacturer need not be reversed in case of a loss incurr...

Inclusion of petroleum products, petrol and diesel within GST is set to be a hot topic of debate as high taxes and cess have pushed fuel pr...

The GST compensation is calculated as per the formula provided in the Compensation Act and is released on a bi-monthly basis. However, due ...

Williams received a SGD1 million cheque of donations collected by the Singapore Indian Chambers of Commerce and Industry (SICCI) and the Li...

Executives at Future Supply Chain, DHL Express, Ecom Express, Safexpress and Spoton Logistics said the operations are beginning to unfreeze...

Addressing a press briefing on the current COVID-19 situation in the country, a senior health ministry official reiterated that there has b...

Investors complained, competitors were mystified and Saldanha's father was skeptical. Nevertheless, Saldanha pressed ahead in the painstaki...

Muhammed Majeed is eyeing cultivation of the monk fruit in India, a zero-calorie, natural sugar substitute that might be the answer to our ...

The CAG today painted a sorry state of affairs at government hospitals in the national capital in its report for the fiscal year ending Mar...

Mylan has sued USFDA for not allowing it to market a generic version of medicine Diovan, saying that Ranbaxy has lost its exclusivity for t...

The company is yet to get the US food and Drug Administration's approval for the generic version of the drug, valsartan.

Pharmaceutical companies, which do not make drugs in excise exempt states, can look forward to a relief in the forthcoming Union Budget.

The USFDA has issued a warning letter to domestic pharma major Ranbaxy for deviations from good manufacturing practices at its Paonta Sahib...